Navigation Links
Dr. Wei Sun, PhD, MD Joins SpectraCell Laboratories
Date:3/6/2008

HOUSTON, March 6 /PRNewswire/ -- SpectraCell Laboratories, Inc., announced that the company has added Dr. Wei Sun, PhD, MD to its scientific staff as Manager of Research & Development.

Dr. Sun comes to SpectraCell Laboratories from the University of Texas M.D. Anderson Cancer Center. He brings eight years of experience in the area of cellular and molecular biology research, as well as research experience within the areas of lymphocyte activation, lymphocyte subset analysis, apoptosis, and T-cell culture.

"Since our nutritional FIA(TM) testing is performed on lymphocytes, bringing in an MD, PhD whose primary experience is with lymphocyte function is a perfect fit for SpectraCell," states Dr. Fred Crawford, VP of Operations to whom Dr. Sun will report. "Having five PhDs and an MD on staff is just another example of our commitment to scientific excellence."

Due to the increasing number of doctors that understand the importance of functional nutritional testing in their practice, SpectraCell continues to grow. The company's number of employees has more than doubled since 2005 and SpectraCell now serves over 3,000 physician clients nationwide.

About SpectraCell Laboratories

SpectraCell is a CLIA accredited laboratory that services healthcare providers nationwide by providing advanced clinical testing with the patented FIA(TM) (Functional Intracellular Analysis) and LPP(TM) (Lipoprotein Particle Profile) tests.

SpectraCell's FIA(TM) testing is an innovative assessment of a patient's nutritional status. Unlike traditional serum, hair and urine tests, SpectraCell's FIA(TM) evaluates how an individual's white blood cells respond to varied environments of over 30 vitamins, minerals, amino acids and antioxidants. As a result, individual differences in metabolism, age, genetics, health, prescription drug usage, absorption rate and other factors are taken into consideration in determining deficiencies that need to be corrected.

SpectraCell's LPP(TM) tests are the most advanced lipoprotein tests available. Unlike traditional cholesterol tests, SpectraCell's LPP(TM) directly measures both the size and number of several classes of lipoprotein particles providing an accurate assessment of cardiovascular risk.


'/>"/>
SOURCE SpectraCell Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Richard Greco Joins Mediware Board
2. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
3. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
4. Dr. Mahesh Ramachandran Joins Marianjoy Medical Group
5. Nick Childs Joins Grey New York as Director of Content Development
6. Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
7. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
8. NASN Joins Partnership to Fight Chronic Disease
9. AstraZeneca Joins Local Walking Movement
10. Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
11. Fund Manager Joins Board of GSI Securitization Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... Splashtop ... Mirroring360 Pro . This new addition to the Mirroring360 product family combines device ... business. , Mirroring360 Pro enables educators, business professionals and individuals to stream or ...
(Date:4/25/2017)... ... April 25, 2017 , ... As President ... are preparing for how his administration could impact the employee benefits industry. James ... changes are most likely to make it through Congress. His discussion will focus ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who would like to ... a fraction of the time as traditional braces – Wilckodontics®. Dr. Victoria Chen, ... offers this revolutionary treatment with or without a referral. , Wilckodontics is ...
(Date:4/25/2017)... ... 2017 , ... Buyers and sellers in the thriving multi-billion dollar cannabis marketplace ... help but be heartened by the industry’s current surge. But another thing that unifies ... smell.” At last they can simply, safely and effectively end their aroma anguish ...
(Date:4/25/2017)... Fl (PRWEB) , ... April 25, 2017 , ... There ... Memorial Regional Hospital, according to a special report in the May issue of Consumer ... its highest quality ranking for results achieved during and after coronary bypass and ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Tenn. and DALLAS , April 19, 2017 ... announced that the first patients in Nashville ... device in the Lower Esophageal Sphincter Stimulation for GERD ... implantable device designed to provide long-term reflux control by ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... SAN DIEGO , April 19, 2017 /PRNewswire/ ... ("Sorrento"), an antibody-centric, clinical-stage biopharmaceutical company developing new ... today announced the closing of its previously announced ... common stock at a public offering price of ... commissions and estimated offering expenses payable by Sorrento.  ...
(Date:4/19/2017)... 2017  New research provides evidence that an old drug ... a study released today that will be presented at the ... Boston , April 22 to 28, 2017. ... Parkinson,s disease, the oral drug levodopa has long been considered ... as the disease progresses, the effects of the medication can ...
Breaking Medicine Technology: